Piper Sandler analyst Jessica Tassan downgraded Oak Street Health (OSH) to Neutral from Overweight with a price target of $39, down from $47, after CVS Health (CVS) announced the acquisition of Oak Street for $39 per share in cash or $10.6B. The analyst downgrades the shares based on the deal terms.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH: